These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29397915)

  • 1. [Gastrointestinal stromal tumors (GIST): The particularities aspects in African countries].
    Togo A; Traoré A; Dembélé BT; Diakité I; Traoré A; Konaté M; Bah A; Kanté L; Koné T; Dicko MY; Yoro Sidibé B; Ahmadou I; Diallo G
    Bull Cancer; 2018 Feb; 105(2):212-213. PubMed ID: 29397915
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China.
    Shi YN; Li Y; Wang LP; Wang ZH; Liang XB; Liang H; Zhang L; Li B; Fan LQ; Zhao Q; Ma ZX; Zhao XF; Zhang ZD; Liu Y; Tan BB; Wang D; Wang LL; Hao YJ; Jia N
    Medicine (Baltimore); 2017 Nov; 96(46):e8240. PubMed ID: 29145240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis.
    Fairweather M; Balachandran VP; Li GZ; Bertagnolli MM; Antonescu C; Tap W; Singer S; DeMatteo RP; Raut CP
    Ann Surg; 2018 Aug; 268(2):296-302. PubMed ID: 28448384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.
    Kim JH; Ryu MH; Yoo C; Chae H; Na H; Beck M; Kim BS; Yoo MW; Yook JH; Kim BS; Kim KH; Kim CW; Kang YK
    Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor.
    Wu X; Li J; Xu W; Gao J; Li Y; Shen L
    Future Oncol; 2018 Jul; 14(17):1721-1729. PubMed ID: 29969914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant Gastric Gastrointestinal Stromal Tumor (GIST).
    Navarrete A; Momblán D; Almenara R; Lacy A
    J Gastrointest Surg; 2017 Jan; 21(1):202-204. PubMed ID: 27384431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Imatinib on Survival and Treatment Trends for Small Bowel and Colorectal Gastrointestinal Stromal Tumors.
    Almaazmi H; Stem M; Lo BD; Taylor JP; Fang SH; Safar B; Efron JE; Atallah C
    J Gastrointest Surg; 2020 Jan; 24(1):98-108. PubMed ID: 31388887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Downsizing of a Gastroesophageal GIST Using Neoadjuvant Imatinib Mesylate: a Case Report.
    Asif S; Gupta N; Gupta G; Mehta A; Singh S
    J Gastrointest Cancer; 2017 Jun; 48(2):198-200. PubMed ID: 27006070
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?
    Sutton TL; Billingsley KG; Johnson AJ; Corless CL; Blanke CD; Heinrich MC; Mayo SC
    J Surg Oncol; 2024 Jul; 130(1):40-46. PubMed ID: 38924626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.
    Cavnar MJ; Wang L; Balachandran VP; Antonescu CR; Tap WD; Keohan M; Singer S; Temple L; Nash GM; Weiser MR; Guillem JG; Aguilar JG; DeMatteo RP; Paty PB
    Ann Surg Oncol; 2017 Dec; 24(13):3972-3980. PubMed ID: 29058144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy options for advanced gastrointestinal stromal tumors beyond first-line imatinib: a systematic review.
    Abdel-Rahman O; Fouad M
    Future Oncol; 2015; 11(12):1829-43. PubMed ID: 26075449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib.
    Jang BH; Kim BW; Lim KJ; Kim BG; Park SM; Kim JS; Ji JS; Choi H
    Korean J Gastroenterol; 2015 Jun; 65(6):366-9. PubMed ID: 26087692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors after imatinib secondary resistance: survival analysis in patients with unresectable and metastatic gastrointestinal stromal tumors.
    Kanda T; Ishikawa T; Kosugi SI; Ueki K; Naito T; Wakai T; Hirota S
    Int J Clin Oncol; 2016 Apr; 21(2):295-301. PubMed ID: 26386705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of surgery in patients with focally progressive gastrointestinal stromal tumors resistant to imatinib.
    Gao X; Xue A; Fang Y; Shu P; Ling J; Qin J; Hou Y; Shen K; Sun Y; Qin X
    Sci Rep; 2016 Mar; 6():22840. PubMed ID: 26946961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH
    Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.
    Keung EZ; Fairweather M; Raut CP
    Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features and prognosis of primary gastrointestinal stromal tumor patients under 35 years of age: A 10-year retrospective study.
    Zhang P; Deng R; Liu K; Shuai XM; Bai J; Chang WL; Gao JB; Cai KL; Wang GB; Tao KX
    J Surg Oncol; 2016 Dec; 114(8):977-981. PubMed ID: 27664034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of the metastatic gastrointestinal stromal tumor after resistance to available tyrosine kinase inhibitors: A case report.
    Zhang H; Mu M; He X; Yin Y
    Asian J Surg; 2023 Feb; 46(2):937-938. PubMed ID: 35963693
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-Term Imatinib Treatment for Patients with Unresectable or Recurrent Gastrointestinal Stromal Tumors.
    Ogata K; Kimura A; Nakazawa N; Suzuki M; Yanoma T; Ubukata Y; Iwamatsu K; Kogure N; Yanai M; Kuwano H
    Digestion; 2018; 97(1):20-25. PubMed ID: 29393163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis.
    Ling JY; Ding MM; Yang ZF; Zhao YD; Xie XY; Shi LS; Wang HM; Cao WT; Zhang JW; Hu HB; Cai Y; Wang H; Deng YH
    J Surg Oncol; 2021 Dec; 124(8):1442-1450. PubMed ID: 34494280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.